{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:24:17Z","timestamp":1788776657216,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1642\/20"],"award-info":[{"award-number":["1642\/20"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.celrep.2024.114920","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T09:46:26Z","timestamp":1730195186000},"page":"114920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Stav","family":"Rabani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Gulsen","family":"Gunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar","family":"Lampert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirly","family":"Becker-Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0004-6159","authenticated-orcid":false,"given":"Idit","family":"Shachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.114920_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer Treatment: A Review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2024.114920_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.celrep.2024.114920_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1758834012475152","article-title":"Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects","volume":"5","author":"Stagg","year":"2013","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.celrep.2024.114920_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12935-020-01418-1","article-title":"EO771, the first luminal B mammary cancer cell line from C57BL\/6 mice","volume":"20","author":"Le Naour","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.celrep.2024.114920_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4161\/cam.20880","article-title":"An \"elite hacker\": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity","volume":"6","author":"Boudreau","year":"2012","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.celrep.2024.114920_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","article-title":"Role of interleukin-10 in breast cancer","volume":"133","author":"Hamidullah","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.celrep.2024.114920_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12885-018-4441-3","article-title":"Mechanisms of immune evasion in breast cancer","volume":"18","author":"Bates","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.celrep.2024.114920_bib8","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1038\/s41467-020-17414-y","article-title":"Exhausted T\u00a0cell signature predicts immunotherapy response in ER-positive breast cancer","volume":"11","author":"Terranova-Barberio","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114920_bib9","article-title":"Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer","volume":"12","author":"Oshi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.celrep.2024.114920_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2618-7","article-title":"Myeloid-derived suppressor cells in breast cancer","volume":"140","author":"Markowitz","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.celrep.2024.114920_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12282-018-0910-4","article-title":"Coexistence of regulatory B cells and regulatory T\u00a0cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer","volume":"26","author":"Ishigami","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.celrep.2024.114920_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00262-011-0972-z","article-title":"The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model","volume":"60","author":"Tadmor","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2024.114920_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","article-title":"Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG","volume":"25","author":"Gu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.114920_bib14","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","article-title":"Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T\u00a0cells to T-regulatory cells","volume":"71","author":"Olkhanud","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2024.114920_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1075112","article-title":"PD-L1 mediated the differentiation of tumor-infiltrating CD19(+) B lymphocytes and T\u00a0cells in Invasive breast cancer","volume":"5","author":"Guan","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.celrep.2024.114920_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.114920_bib17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/00007890-199306000-00027","article-title":"CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells","volume":"55","author":"Monach","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.celrep.2024.114920_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4049\/jimmunol.121.1.359","article-title":"Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor","volume":"121","author":"Brodt","year":"1978","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib19","doi-asserted-by":"crossref","first-page":"16248","DOI":"10.18632\/oncotarget.24575","article-title":"Signaling lymphocytic activation molecules Slam and cancers: friends or foes?","volume":"9","author":"Fouquet","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2024.114920_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coi.2015.11.003","article-title":"SLAM family receptors in normal immunity and immune pathologies","volume":"38","author":"Wu","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2018.10.017","article-title":"CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders","volume":"204","author":"Cuenca","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/onc.2013.31","article-title":"CD84 is a survival receptor for CLL cells","volume":"33","author":"Binsky-Ehrenreich","year":"2014","journal-title":"Oncogene."},{"key":"10.1016\/j.celrep.2024.114920_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/onc.2016.238","article-title":"CD84 mediates CLL-microenvironment interactions","volume":"36","author":"Marom","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2024.114920_bib24","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1172\/JCI96610","article-title":"CD84 regulates PD-1\/PD-L1 expression and function in chronic lymphocytic leukemia","volume":"128","author":"Lewinsky","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2024.114920_bib25","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41467-021-22230-z","article-title":"The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5","volume":"12","author":"Radomir","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114920_bib26","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.celrep.2019.10.018","article-title":"Aryl Hydrocarbon Receptor Contributes to the Transcriptional Program of IL-10-Producing Regulatory B Cells","volume":"29","author":"Piper","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114920_bib58","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","article-title":"Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer","volume":"19","author":"Gyorffy","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.celrep.2024.114920_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104063","article-title":"Stromal cell diversity associated with immune evasion in human triple-negative breast cancer","volume":"39","author":"Wu","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2024.114920_bib30","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2024.114920_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114920_bib29","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114920_bib31","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41467-021-22300-2","article-title":"Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114920_bib32","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114920_bib33","article-title":"CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma","volume":"6","author":"Lewinsky","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2024.114920_bib34","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.4049\/jimmunol.0900185","article-title":"Nonredundant roles for B cell-derived IL-10 in immune counter-regulation","volume":"183","author":"Madan","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10549-011-1647-3","article-title":"CD8(+) cytotoxic T\u00a0cell and FOXP3(+) regulatory T\u00a0cell infiltration in relation to breast cancer survival and molecular subtypes","volume":"130","author":"Liu","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.celrep.2024.114920_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay6017","article-title":"Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics","volume":"5","author":"Alshetaiwi","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib37","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","article-title":"Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review","volume":"2","author":"Stanton","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.celrep.2024.114920_bib38","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582657","article-title":"Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer","volume":"11","author":"Shang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib40","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.celrep.2015.09.070","article-title":"Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells","volume":"13","author":"Sun","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114920_bib41","doi-asserted-by":"crossref","first-page":"42276","DOI":"10.18632\/oncotarget.5514","article-title":"Involvement of Wnt\/beta-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2024.114920_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","article-title":"Wnt\/beta-catenin pathway: modulating anticancer immune response","volume":"10","author":"Pai","year":"2017","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.celrep.2024.114920_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/15592294.2016.1249089","article-title":"Identification and characterization of PKF118-310 as a KDM4A inhibitor","volume":"12","author":"Franci","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/j.celrep.2024.114920_bib44","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00262-005-0703-4","article-title":"Tumor immunity: a balancing act between T\u00a0cell activation, macrophage activation and tumor-induced immune suppression","volume":"54","author":"Sinha","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2024.114920_bib45","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1180485","article-title":"Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-kappaB signal pathway","volume":"5","author":"Zhou","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.celrep.2024.114920_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12967-014-0304-0","article-title":"Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer","volume":"12","author":"Zhou","year":"2014","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.celrep.2024.114920_bib47","doi-asserted-by":"crossref","first-page":"14803","DOI":"10.18632\/oncotarget.22976","article-title":"Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1\/PD-L1 pathway","volume":"9","author":"Zhao","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2024.114920_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.celrep.2024.114920_bib49","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.4049\/jimmunol.181.6.3777","article-title":"Role of beta-catenin in B cell development and function","volume":"181","author":"Yu","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib50","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/beta-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.114920_bib51","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.0902360","article-title":"Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors","volume":"184","author":"Ojalvo","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.114920_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/srep12465","article-title":"Blockade of Wnt\/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype","volume":"5","author":"Jang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2024.114920_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcb.23350","article-title":"The Wnt\/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer","volume":"113","author":"King","year":"2012","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.celrep.2024.114920_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1189\/jlb.0613330","article-title":"beta-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8(+) T\u00a0cells","volume":"95","author":"Liang","year":"2014","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.celrep.2024.114920_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1158\/0008-5472.CAN-14-2377","article-title":"beta-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells","volume":"75","author":"Hong","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2024.114920_bib56","doi-asserted-by":"crossref","first-page":"15168","DOI":"10.18632\/oncotarget.14834","article-title":"Colorectal cancer cells suppress CD4+ T\u00a0cells immunity through canonical Wnt signaling","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2024.114920_bib57","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1089\/jir.2006.26.893","article-title":"Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling","volume":"26","author":"Samarasinghe","year":"2006","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.celrep.2024.114920_bib64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nprot.2013.023","article-title":"High-throughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states","volume":"8","author":"Blecher-Gonen","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2024.114920_bib63","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2024.114920_bib59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2010.01.010","article-title":"Optimal Germinal Center Responses Require a Multistage T Cell:B Cell Adhesion Process Involving Integrins, SLAM-Associated Protein, and CD84","volume":"32","author":"Cannons","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.114920_bib60","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/s41596-019-0164-4","article-title":"MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing","volume":"14","author":"Keren-Shaul","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2024.114920_bib61","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1073\/pnas.1612195114","article-title":"CD74 is a novel transcription regulator","volume":"114","author":"Gil-Yarom","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114920_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111572","article-title":"CD74 as a regulator of transcription in normal B cells","volume":"41","author":"David","year":"2022","journal-title":"Cell Rep."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724012713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724012713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:46:15Z","timestamp":1773236775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724012713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2211124724012713"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114920","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114920"}}